Literature DB >> 8856350

Assays for antibodies to varicella-zoster virus.

D L Krah1.   

Abstract

Anti-varicella-zoster virus serum antibody assays and their use in vaccine development are described. Of particular interest are FAMA and neutralization assays and the gpELISA. These and other assays are compared and summarized in terms of characteristics including biologic relevance, sensitivity, specificity, and suitability for different laboratory and clinical applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856350     DOI: 10.1016/s0891-5520(05)70311-1

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  11 in total

1.  Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.

Authors:  G Vandersmissen; G Moens; R Vranckx; A de Schryver; P Jacques
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

2.  Evaluation of a multiplex bead immunoassay for determination of immune status to varicella-zoster virus in medical center students and employees.

Authors:  Michael J Loeffelholz; Harry E Prince
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

3.  Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.

Authors:  Andreas Sauerbrei; Anna Schäfler; Jörg Hofmann; Michael Schacke; Bernd Gruhn; Peter Wutzler
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

4.  Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.

Authors:  A Sauerbrei; P Wutzler
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 5.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

6.  Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Gray; J Breuer; G Kafatos; S Parker; D Brown
Journal:  Clin Vaccine Immunol       Date:  2006-02

7.  Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella.

Authors:  Yun Hwa Kim; Ji Young Hwang; Hye Min Shim; Eunsil Lee; Songyong Park; Hosun Park
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

8.  Negative IgG Varicella Zoster Virus Antibody Status: Immune Responses Pre and Post Re-immunization.

Authors:  Tamar A Smith-Norowitz; Tehila A Saadia; Kevin B Norowitz; Rauno Joks; Helen G Durkin; Stephan Kohlhoff
Journal:  Infect Dis Ther       Date:  2017-12-22

9.  Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.

Authors:  Miriam Wiese-Posselt; Anette Siedler; Annette Mankertz; Andreas Sauerbrei; Hartmut Hengel; Ole Wichmann; Christina Poethko-Müller
Journal:  BMC Infect Dis       Date:  2017-05-19       Impact factor: 3.090

10.  Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200.

Authors:  Elizabeth McLachlan; Heidi Scholz; Shelly Bolotin; Natasha S Crowcroft; Todd F Hatchette; Colleen Jackson; Alberto Severini
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.